Lv4
714 积分 2026-07-08 加入
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
11分钟前
待确认
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD
1小时前
待确认
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
1小时前
已完结
Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder
1小时前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
2天前
已完结
Immuno-pathogenesis of neuromyelitis optica and emerging therapies
2天前
已完结
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD
1个月前
已完结
Should We Measure CSF Complement Levels in Patients With MOGAD?
1个月前
已完结
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD
1个月前
已完结
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study
1个月前
已完结
皖公网安备34019202002308
